SECTION I: Introdcution to PET/MR
Introduction to PET/MR
SECTION II: Public Health and Economic Implications
Utility of PET/MRI in Private Practice
SECTION III: Physics of PET/MR Systems
Physics of PET/MR Systems
SECTION IV: Overview of Hot Lab and Cyclotron
Overview of Hot Lab and Cyclotron
SECTION V: Radiotracers in Neurologic PET/MRI
FDG Metabolic Imaging
Amyloid Dementia Imaging
TAU Dementia Imaging
Amino Acid Tumor Imaging
FDOPA Dopaminergic Imaging
DASB Serotonin Receptor Imaging
FEPPA Microglial Activation Imaging
[150]-H2O/CO2 Perfusion Imaging
Fluciclovine (Axumin) glioma imaging
Ga68 Dotatate neuroendocrine imaging
Radiotracers in development
SECTION VI: Dementia and Neurodegenerative Disease
Alzheimers disease
MCI and dementia therapeutics
Posterior cortical atrophy
Dementia with Lewy Body
Behavioral variant FTD (Picks disease)
Semantic dementia
Logopenic PPA
Agrammatic PPA
Progressive supranuclear palsy
Multisystem atrophy
Corticobasal degeneration
Creutzfeld-Jacob disease
Normal pressure hydrocephalus
Crossed cerebellar diaschisis
SECTION VII: Epilepsy Localization
Seizure Focus Localization
Developmental
Acquired
SECTION VIII: Brain Tumors
Diagnosis
Primary Brain Neoplasms
Metastatic Disease
Treatment Planning
Treatment Response
SECTION IX: Inflammatory and Infectious CNS Disorders
Meningitis
Encephalitis
CNS Inflammatory Disease
Demyelinating Disease
Vasculitis
SECTION X: Hybrid Imaging in Head and Neck
Role of PET/MR in tumor staging
Mucosal and nodal disease in the head and neck
Extranodal disease in the head and neck
Metastatic disease in the head and neck
Salivary gland pathology
Orbital pathology
SECTION XI: Spine PET/MR
Neoplastic Disease
Non-Neoplastic
SECTION XII: Vascular Hybrid Imaging
Ischemic Disease
Aneurysms and Vascular Malformations
Genetic Disorders
Perfusion and PET
Advanced MR Techniques
SECTION XIII: Future Trends
Artificial Intelligence
Utility of AI in Dementia/Neuroimaging.